GBT is Enhancing its Avant! AI Technology to Support Healthcare Advisory System
GBT Technologies Inc. (GTCH) is advancing its Avant! AI technology to improve user experience and connect with health data resources. The company is enhancing the back-end architecture for better imaging and user interfaces, targeting a more efficient healthcare advisory system. The enhancements include advanced image recognition and robust Q/A capabilities. The upgraded system aims to provide reliable health advice and assist healthcare professionals, particularly in remote areas. A new version of the mobile and web applications is expected in the coming months.
- Enhancement of Avant! AI technology focusing on healthcare advisory.
- Improved user interface for better human-computer interaction.
- Integration with accredited health-related data resources.
- Planned implementation of advanced image recognition techniques.
- None.
Improving overall Avant! mobile and web user’s experience, and connecting it with health-related data resources!
SAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”), is enhancing its Avant! AI technology, while enabling a healthcare advisory system. The company is in the process of an enhancement phase to improve Avant! back-end architecture, supporting better imaging and user interface. Advanced image recognition techniques are planned for implementation combined with efficient memory handling to enable faster performance.
Avant! dialog interface is being enhanced, enabling robust Q/A possibilities combined with easier user interactions. Avant! will be trained with health-related information and connected with accredited data resources, enabling a generalized health advisory system; and will consider a domain-specific later. Avant! AI belongs to an emerging generation of chat-based artificial intelligence applications that enable a user’s conversation through a chat dialog interface, allowing it to understand and respond to questions and natural language inputs.
GBT is developing the system to address the needs of a new era of intelligent telemedicine, one that will assist patients and healthcare specialists through connected devices. Its AI-driven solutions aim to benefit users, while addressing the unique challenges of the fastest growing healthcare segment. These intelligent advisory capabilities target to effectively provide reliable, first line, real-time, health related advice worldwide. Avant! enhancement phase targets completion during the next few months, after which we will release a new version of both mobile and web applications.
“Avant! AI is capable of being an efficient data-driven information agent; currently, it’s released as an AGI (Artificial General Intelligence) agent and we have decided to focus on a more specific field. Naturally, due to the world’s health crisis special attention will be given to the health domain, and we are going to enable Avant! to become a knowledge-based health advisory system. It will be connected to credible health-related resources set to respond to general health related questions. We are implementing a series of enhancements to handle big-data with better understanding of the user’s question capabilities, users will be able to get first-line, relevant advice; 24/7. Avant! health agent will also be aimed as an assisting tool for healthcare professionals; especially, assisting remote locations. Additionally, we are enhancing the user interface to improve the human-to-computer experience, making it more user friendly; mainly intuitive. GBT uses artificial intelligence solutions to create health assistance and monitoring value; particularly, in this new era of telemedicine. Our AI technology can also become an innovative foundation of the future patient-clinic experience, changing the way our world practices medicine,” said Danny Rittman the Company’s CTO.
About Us
GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.
Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
Contact:
Dr. Danny Rittman, CTO
press@gopherprotocol.com
FAQ
What is GBT Technologies focusing on with the Avant! AI technology?
When will the new version of Avant! be released?
How will Avant! AI assist healthcare professionals?
What improvements are being made to the Avant! AI interface?
